ATE543495T1 - Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür - Google Patents

Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür

Info

Publication number
ATE543495T1
ATE543495T1 AT06791135T AT06791135T ATE543495T1 AT E543495 T1 ATE543495 T1 AT E543495T1 AT 06791135 T AT06791135 T AT 06791135T AT 06791135 T AT06791135 T AT 06791135T AT E543495 T1 ATE543495 T1 AT E543495T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
ruthenium
composition containing
oxalato compound
oxalato
Prior art date
Application number
AT06791135T
Other languages
English (en)
Inventor
Chi-Ming Che
Raymond Sun
Ella Wong
Original Assignee
Univ Hong Kong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong filed Critical Univ Hong Kong
Application granted granted Critical
Publication of ATE543495T1 publication Critical patent/ATE543495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C07F15/0053—Ruthenium compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06791135T 2005-10-24 2006-09-28 Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür ATE543495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/256,175 US7648977B2 (en) 2005-10-24 2005-10-24 Pharmaceutical composition having a ruthenium oxalato compound and method of using the same
PCT/CN2006/002547 WO2007048311A1 (en) 2005-10-24 2006-09-28 Pharmaceutical composition having a ruthenium oxalato compound and method of using the same

Publications (1)

Publication Number Publication Date
ATE543495T1 true ATE543495T1 (de) 2012-02-15

Family

ID=37967402

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06791135T ATE543495T1 (de) 2005-10-24 2006-09-28 Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür

Country Status (5)

Country Link
US (1) US7648977B2 (de)
EP (1) EP1940385B1 (de)
CN (1) CN101378748B (de)
AT (1) ATE543495T1 (de)
WO (1) WO2007048311A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1109890A (en) * 1965-12-21 1968-04-18 Int Nickel Ltd Preparation of finely divided metals
WO1995031202A1 (en) * 1994-05-17 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Cage compounds, processes for their preparation and their use as antiviral agents
US5514995A (en) * 1995-01-30 1996-05-07 Micrel, Inc. PCMCIA power interface
DE19736609A1 (de) * 1997-08-22 1999-02-25 Basf Ag Verfahren zur Herstellung von Rutheniumkomplexen
JP4780834B2 (ja) * 1998-10-22 2011-09-28 フィリップ・ビー・ビー・モヘノ 新規なプテリン抗新生物薬
TWI228051B (en) * 2003-05-19 2005-02-21 Well Being Biochemical Corp Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use

Also Published As

Publication number Publication date
EP1940385A1 (de) 2008-07-09
CN101378748A (zh) 2009-03-04
WO2007048311A1 (en) 2007-05-03
CN101378748B (zh) 2011-05-18
US20070105952A1 (en) 2007-05-10
EP1940385A4 (de) 2010-09-22
US7648977B2 (en) 2010-01-19
EP1940385B1 (de) 2012-02-01

Similar Documents

Publication Publication Date Title
MX2013005478A (es) Compuestos heterociclicos condensados antivirales.
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
BR112012018670A2 (pt) combinação, uso de um composto, composição farmacêutica, e, pacote de paciente
MX2010005292A (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
ATE530561T1 (de) 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion
NZ585226A (en) Inhibitors of human immunodeficiency virus replication
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
MX2012007410A (es) Compuestos antivirales novedosos.
TW200615266A (en) Organic compounds
EA200801997A1 (ru) Новые соединения
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
MX2009013501A (es) Compuestos piperidinicos y sus usos.
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
TW200716618A (en) Chemical compounds
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
MX2009006311A (es) Terapia de combinacion para tratar infecciones de hepatitis c.
ATE487492T1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
ATE370733T1 (de) Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen